Chitraporn Karnasuta

Summary

Affiliation: Armed Forces Research Institute of Medical Sciences
Country: Thailand

Publications

  1. ncbi request reprint Enhanced sensitivity of detection of cytotoxic T lymphocyte responses to HIV type 1 proteins using an extended in vitro stimulation period for measuring effector function in volunteers enrolled in an ALVAC-HIV phase I/II prime boost vaccine trial in Thail
    Wannee Kantakamalakul
    Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
    AIDS Res Hum Retroviruses 20:642-4. 2004
  2. ncbi request reprint Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand
    Chitraporn Karnasuta
    Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Vaccine 23:2522-9. 2005
  3. ncbi request reprint A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost
    Prasert Thongcharoen
    Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand
    J Acquir Immune Defic Syndr 46:48-55. 2007
  4. ncbi request reprint Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults
    Sorachai Nitayaphan
    Royal Thai Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    J Infect Dis 190:702-6. 2004
  5. doi request reprint HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX(®) B/E
    Robert Paris
    Department of Retrovirology and Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Vaccine 30:832-6. 2012
  6. doi request reprint Comparison of Antibody Responses Induced by RV144, VAX003 and VAX004 Vaccination Regimens
    Chitraporn Karnasuta
    Armed Forces Research Institute of Medical Sciences, 19965, Retrovirology, Bangkok, Thailand
    AIDS Res Hum Retroviruses . 2016
  7. pmc IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
    Nicos Karasavvas
    1 Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    AIDS Res Hum Retroviruses 31:1178-86. 2015
  8. ncbi request reprint Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans
    Michael A Eller
    Makerere University Walter Reed Project, Kampala, Uganda
    Vaccine 25:7737-42. 2007

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Enhanced sensitivity of detection of cytotoxic T lymphocyte responses to HIV type 1 proteins using an extended in vitro stimulation period for measuring effector function in volunteers enrolled in an ALVAC-HIV phase I/II prime boost vaccine trial in Thail
    Wannee Kantakamalakul
    Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
    AIDS Res Hum Retroviruses 20:642-4. 2004
    ..These results imply that extension of the IVS period may increase the sensitivity of the CRA when measuring HIV-specific CTL in ALVAC-HIV prime-boost recipients without compromising specificity...
  2. ncbi request reprint Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand
    Chitraporn Karnasuta
    Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Vaccine 23:2522-9. 2005
    ..The results demonstrate that this HIV vaccine is a potent inducer of ADCC activity and may be an additional protection of this prime-boost vaccine in preventing HIV disease...
  3. ncbi request reprint A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost
    Prasert Thongcharoen
    Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand
    J Acquir Immune Defic Syndr 46:48-55. 2007
    ..A prime-boost HIV-1 vaccine trial assessing safety and immunogenicity was conducted in Thailand as part of an evaluation of candidate regimens for a phase 3 efficacy trial...
  4. ncbi request reprint Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults
    Sorachai Nitayaphan
    Royal Thai Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    J Infect Dis 190:702-6. 2004
    ..This vaccine combination was well tolerated and was immunogenic, meeting milestones for advancement to phase 3 evaluation...
  5. doi request reprint HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX(®) B/E
    Robert Paris
    Department of Retrovirology and Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Vaccine 30:832-6. 2012
    ..009). These data suggest that the lack of response to a vaccine designed to induce clade-specific NAb to HIV-1 is associated with the presence of certain HLA class II alleles and heterodimers in some Southeast Asians...
  6. doi request reprint Comparison of Antibody Responses Induced by RV144, VAX003 and VAX004 Vaccination Regimens
    Chitraporn Karnasuta
    Armed Forces Research Institute of Medical Sciences, 19965, Retrovirology, Bangkok, Thailand
    AIDS Res Hum Retroviruses . 2016
    ....
  7. pmc IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
    Nicos Karasavvas
    1 Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    AIDS Res Hum Retroviruses 31:1178-86. 2015
    ..However, notable differences in the structure of the recombinant proteins and dosage used for immunizations may have contributed to the magnitude and specificity of IgG induced by the two trials. ..
  8. ncbi request reprint Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans
    Michael A Eller
    Makerere University Walter Reed Project, Kampala, Uganda
    Vaccine 25:7737-42. 2007
    ....